We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common use of No Financial Advisors Clause in Contracts

No Financial Advisors. Except as set forth in Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 12 contracts

Samples: Merger Agreement (Traws Pharma, Inc.), Merger Agreement (Spyre Therapeutics, Inc.), Merger Agreement (Aeglea BioTherapeutics, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or any of its Subsidiaries.

Appears in 11 contracts

Samples: Agreement and Plan of Merger (Terra Tech Corp.), Merger Agreement (DelMar Pharmaceuticals, Inc.), Merger Agreement (Conatus Pharmaceuticals Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 9 contracts

Samples: Agreement and Plan of Merger and Reorganization (Portage Biotech Inc.), Merger Agreement (Anchiano Therapeutics Ltd.), Merger Agreement (Sunesis Pharmaceuticals Inc)

No Financial Advisors. Except as set forth in on Section 2.20 3.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 8 contracts

Samples: Merger Agreement (TRxADE HEALTH, INC), Merger Agreement (AVROBIO, Inc.), Merger Agreement (Fresh Vine Wine, Inc.)

No Financial Advisors. Except as set forth in Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or any of its Subsidiaries.

Appears in 5 contracts

Samples: Merger Agreement (Kidpik Corp.), Merger Agreement (Angion Biomedica Corp.), Merger Agreement (AgeX Therapeutics, Inc.)

No Financial Advisors. Except as set forth in Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or any of its Subsidiaries.

Appears in 5 contracts

Samples: Merger Agreement (Bell Robert G.), Merger Agreement (Tanimoto Sarina), Merger Agreement (Silverback Therapeutics, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or any of its Subsidiaries.

Appears in 3 contracts

Samples: Merger Agreement (Synlogic, Inc.), Merger Agreement (Mirna Therapeutics, Inc.), Merger Agreement (Nivalis Therapeutics, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 3.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or any of its Subsidiaries.

Appears in 3 contracts

Samples: Merger Agreement (Ikena Oncology, Inc.), Merger Agreement (Vascular Biogenics Ltd.), Merger Agreement (Gemini Therapeutics, Inc. /DE)

No Financial Advisors. Except as set forth in on Section 2.20 3.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or any of its Subsidiaries.

Appears in 2 contracts

Samples: Merger Agreement (Talaris Therapeutics, Inc.), Merger Agreement (Zafgen, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 ‎2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 2 contracts

Samples: Merger Agreement (SciSparc Ltd.), Merger Agreement (Anchiano Therapeutics Ltd.)

No Financial Advisors. Except as set forth in on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany Group.

Appears in 2 contracts

Samples: Merger Agreement (Kubient, Inc.), Merger Agreement (Kubient, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 3.20 of the Company Korro Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyXxxxx.

Appears in 1 contract

Samples: Merger Agreement (Frequency Therapeutics, Inc.)

No Financial Advisors. Except as set forth in Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or the Company Subsidiary.

Appears in 1 contract

Samples: Merger Agreement (Aduro Biotech, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 3.21 of the Company ADES Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyADES or its Subsidiaries.

Appears in 1 contract

Samples: Securities Purchase Agreement (Advanced Emissions Solutions, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 of the Company Disclosure ScheduleSchedule and other than Xxxx Xxxxxxxxxxxx Advisors LLC, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or any of its Subsidiaries.

Appears in 1 contract

Samples: Merger Agreement (Seachange International Inc)

No Financial Advisors. Except as set forth in on Section 2.20 4.22 of the Company ADES Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyADES or its Subsidiaries.

Appears in 1 contract

Samples: Transaction Agreement (Advanced Emissions Solutions, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.with

Appears in 1 contract

Samples: Merger Agreement (Caladrius Biosciences, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 1 contract

Samples: Merger Agreement (Mer Telemanagement Solutions LTD)

No Financial Advisors. Except as set forth in on Section 2.20 3.20 of the Company Disclosure Schedule, no broker, finder finder, or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 1 contract

Samples: Merger Agreement (Ikena Oncology, Inc.)

No Financial Advisors. Except as set forth in Section 2.20 of the Company Disclosure Scheduleon Schedule 2.20, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 1 contract

Samples: Merger Agreement (Cara Therapeutics, Inc.)

No Financial Advisors. Except as set forth in Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or its Subsidiary.

Appears in 1 contract

Samples: Merger Agreement (BiomX Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee, service fee or other fee fee, commission or commission expense in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 1 contract

Samples: Merger Agreement (OncoMed Pharmaceuticals Inc)

No Financial Advisors. Except as set forth in on Section 2.20 ‎3.20 of the Company Disclosure ScheduleLetter, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 1 contract

Samples: Merger Agreement (Pulmatrix, Inc.)

No Financial Advisors. Except as set forth in on Section 2.20 3.20 of the Company Disclosure ScheduleLetter, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company.

Appears in 1 contract

Samples: Merger Agreement (ARCA Biopharma, Inc.)

No Financial Advisors. Except as set forth in Section 2.20 of the Company Disclosure Schedule, no broker, finder finder, or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the CompanyCompany or its Subsidiaries.

Appears in 1 contract

Samples: Merger Agreement (Baudax Bio, Inc.)